Sustained efforts through the winter weeks of December saw a few blood donation drives materialize in the month of January 2016. Plenty of small blood donation drives in apartments and malls were organized right through the month.
On 10th January 2016 we had the 5th Bombay blood group donor meet - the get together of the every special people who have the Bombay blood group. The meeting provides a unique opportunity for people with this rare blood group to come together and deliberate upon issues related to the donation, requests and management of Bombay blood group. The regular donors are happy to see each other and the volunteers who they interact with telephonically. It also enables the new members of the community to feel greater comfort in company of many people who share their blood group.
Dr. Lawrence Faulkner. Director Sankalp-People Tree Hospitals Bone Marrow Transplant Unit, Bangalore, India and Medical Coordinator Cure2Children Foundation Florence, Italy.
The ideal cure for thalassemia, or for any other genetic disorder, would be to selectively correct the faulty gene in the relevant cell type in a safe, effective and affordable way.
21st January was a landmark day. It was the day when we discharged the 10th children from Sankalp-People Tree Center for Pediatric Bone Marrow Transplantation. The center which was inaugurated on 27th August 2015 has cured the first 10 children from thalassemia. All the children are doing well.
We undertook the responsibility of offering a reliable, rational and affordable cure from thalassemia and we are happy to share that with 100% success in the first 10 transplants we have made firm progress.
Organizing blood donation drives in December has always been a challenge given the fact that most individuals, corporates, students are all on vacations or prefer to spend time at home with families in order to come back afresh for the upcoming new year. Unfortunately the Chennai floods had it’s impact on blood donation drives in Bangalore as well.
We undertook the responsibility of offering a reliable, rational and affordable cure from thalassemia and we are happy to share that with 100% success in the first 10 transplants we have made firm progress.